These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27566819)

  • 21. High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use.
    Ruiz-Mateos E; Ruiz-León MJ; Tarancón-Díez L; Gutiérrez C; Dronda F; Domínguez-Molina B; Pérez-Elías MJ; Moreno A; Leal M; Moreno S; Vallejo A
    Virus Res; 2019 Apr; 264():40-44. PubMed ID: 30776394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
    Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood.
    Hocini H; Bonnabau H; Lacabaratz C; Lefebvre C; Tisserand P; Foucat E; Lelièvre JD; Lambotte O; Saez-Cirion A; Versmisse P; Thiébaut R; Lévy Y
    J Virol; 2019 May; 93(10):. PubMed ID: 30814287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8+ T cells from HIV type 1-seronegative individuals suppress virus replication in acutely infected cells.
    Røsok B; Voltersvik P; Larsson BM; Albert J; Brinchmann JE; Asjö B
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):79-85. PubMed ID: 8989430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
    Ganesh A; Lemongello D; Lee E; Peterson J; McLaughlin BE; Ferre AL; Gillespie GM; Fuchs D; Deeks SG; Hunt PW; Price RW; Spudich SS; Shacklett BL
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):791-800. PubMed ID: 27019338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.
    Lécuroux C; Girault I; Boutboul F; Urrutia A; Goujard C; Meyer L; Lambotte O; Chaix ML; Martinez V; Autran B; Sinet M; Venet A; ; ;
    AIDS; 2009 Aug; 23(13):1649-58. PubMed ID: 19617814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers.
    Williams LD; Bansal A; Sabbaj S; Heath SL; Song W; Tang J; Zajac AJ; Goepfert PA
    J Virol; 2011 Mar; 85(5):2316-24. PubMed ID: 21159862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses.
    Ndhlovu ZM; Proudfoot J; Cesa K; Alvino DM; McMullen A; Vine S; Stampouloglou E; Piechocka-Trocha A; Walker BD; Pereyra F
    J Virol; 2012 Jun; 86(12):6959-69. PubMed ID: 22514340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic plasticity of HIV-specific CD8
    Angin M; Volant S; Passaes C; Lecuroux C; Monceaux V; Dillies MA; Valle-Casuso JC; Pancino G; Vaslin B; Le Grand R; Weiss L; Goujard C; Meyer L; Boufassa F; Müller-Trutwin M; Lambotte O; Sáez-Cirión A
    Nat Metab; 2019 Jul; 1(7):704-716. PubMed ID: 32694646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Both HLA-B*57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers.
    Lécuroux C; Sáez-Cirión A; Girault I; Versmisse P; Boufassa F; Avettand-Fenoël V; Rouzioux C; Meyer L; Pancino G; Lambotte O; Sinet M; Venet A
    J Virol; 2014 Jan; 88(1):176-87. PubMed ID: 24131719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of HIV viraemic controllers and noncontrollers with normal CD4 counts is exclusively determined by antigen-specific CD8+ T-cell-mediated HIV suppression.
    Tansiri Y; Rowland-Jones SL; Ananworanich J; Hansasuta P
    PLoS One; 2015; 10(3):e0118871. PubMed ID: 25764310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study.
    Potter SJ; Lacabaratz C; Lambotte O; Perez-Patrigeon S; Vingert B; Sinet M; Colle JH; Urrutia A; Scott-Algara D; Boufassa F; Delfraissy JF; Thèze J; Venet A; Chakrabarti LA
    J Virol; 2007 Dec; 81(24):13904-15. PubMed ID: 17928341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses.
    Sáez-Cirión A; Shin SY; Versmisse P; Barré-Sinoussi F; Pancino G
    Nat Protoc; 2010 Jun; 5(6):1033-41. PubMed ID: 20539279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged
    Adams P; Iserentant G; Servais JY; Vandekerckhove L; Vanham G; Seguin-Devaux C;
    Front Immunol; 2020; 11():622343. PubMed ID: 33717056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties.
    Vigano S; Negron J; Ouyang Z; Rosenberg ES; Walker BD; Lichterfeld M; Yu XG
    J Virol; 2015 Aug; 89(15):7829-40. PubMed ID: 25995260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-Cell Subsets (T
    Meraviglia S; Di Carlo P; Pampinella D; Guadagnino G; Presti EL; Orlando V; Marchetti G; Dieli F; Sergi C
    Ann Clin Lab Sci; 2019 Sep; 49(4):519-528. PubMed ID: 31471343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High eomesodermin expression among CD57+ CD8+ T cells identifies a CD8+ T cell subset associated with viral control during chronic human immunodeficiency virus infection.
    Simonetta F; Hua S; Lécuroux C; Gérard S; Boufassa F; Sáez-Cirión A; Pancino G; Goujard C; Lambotte O; Venet A; Bourgeois C
    J Virol; 2014 Oct; 88(20):11861-71. PubMed ID: 25100841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.
    Hersperger AR; Pereyra F; Nason M; Demers K; Sheth P; Shin LY; Kovacs CM; Rodriguez B; Sieg SF; Teixeira-Johnson L; Gudonis D; Goepfert PA; Lederman MM; Frank I; Makedonas G; Kaul R; Walker BD; Betts MR
    PLoS Pathog; 2010 May; 6(5):e1000917. PubMed ID: 20523897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV "elite controllers" are characterized by a high frequency of memory CD8+ CD73+ T cells involved in the antigen-specific CD8+ T-cell response.
    Carrière M; Lacabaratz C; Kök A; Benne C; Jenabian MA; Casartelli N; Hüe S; Hocqueloux L; Lelièvre JD; Lévy Y
    J Infect Dis; 2014 May; 209(9):1321-30. PubMed ID: 24357632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.